According to Inovio Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.14 B. an increase over its 2022 earnings that were of -$0.28 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.14 B | -51.56% |
2022 | -$0.28 B | -8.26% |
2021 | -$0.31 B | 95.4% |
2020 | -$0.16 B | 36.62% |
2019 | -$0.12 B | 20.19% |
2018 | -$93.91 M | 10.94% |
2017 | -$84.65 M | 9.59% |
2016 | -$77.24 M | 118.9% |
2015 | -$35.29 M | -10.67% |
2014 | -$39.5 M | 83.32% |
2013 | -$21.55 M | |
2011 | -$22.23 M | 15.64% |
2010 | -$19.23 M | 37.7% |
2009 | -$13.96 M | 2.19% |
2008 | -$13.66 M | -14.09% |
2007 | -$15.9 M | 19.12% |
2006 | -$13.35 M | 9.62% |
2005 | -$12.18 M | 5.77% |
2004 | -$11.52 M | 73.08% |
2003 | -$6.66 M | 12.75% |
2002 | -$5.9 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | -12,775.60% | ๐บ๐ธ USA |
Novartis NVS | $9.82 B | -7,439.33% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | -2,539.97% | ๐บ๐ธ USA |
Gilead Sciences GILD | $6.85 B | -5,222.67% | ๐บ๐ธ USA |
Merck MRK | $3.03 B | -2,366.70% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $7.53 B | -5,727.56% | ๐ฌ๐ง UK |
Cleveland BioLabs
CBLI | -$2.76 M | -97.94% | ๐บ๐ธ USA |
Arrowhead Pharmaceuticals
ARWR | -$0.29 B | 111.02% | ๐บ๐ธ USA |